메뉴 건너뛰기




Volumn 16, Issue 1, 2012, Pages 130-135

Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients

Author keywords

Active vitamin D sterols; Gender; Parathyroid hormone; Renin angiotensin system inhibitors; Secondary hyperparathyroidism

Indexed keywords

ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM; CREATININE; PARATHYROID HORMONE; PHOSPHATE; RENIN ANGIOTENSIN SYSTEM INHIBITOR; RENIN INHIBITOR; UNCLASSIFIED DRUG; VITAMIN D;

EID: 84858276072     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0534-x     Document Type: Article
Times cited : (16)

References (21)
  • 2
    • 33845700085 scopus 로고    scopus 로고
    • Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
    • DOI 10.1038/sj.ki.5002009, PII 5002009
    • Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31-8. (Pubitemid 44967731)
    • (2007) Kidney International , vol.71 , Issue.1 , pp. 31-38
    • Levin, A.1    Bakris, G.L.2    Molitch, M.3    Smulders, M.4    Tian, J.5    Williams, L.A.6    Andress, D.L.7
  • 5
    • 64949152754 scopus 로고    scopus 로고
    • Hyperparathyroidism in chronic kidney disease: A retrospective cohort study of costs and outcomes
    • Smith DH, Johnson ES, Thorp ML, Yang X, Neil N. Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes. J Bone Miner Metab. 2009;27:287-94.
    • (2009) J Bone Miner Metab , vol.27 , pp. 287-294
    • Smith, D.H.1    Johnson, E.S.2    Thorp, M.L.3    Yang, X.4    Neil, N.5
  • 6
    • 43749124436 scopus 로고    scopus 로고
    • Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease
    • DOI 10.1038/ki.2008.64, PII KI200864
    • Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar Zadeh K. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008;73:1296-302. (Pubitemid 351693159)
    • (2008) Kidney International , vol.73 , Issue.11 , pp. 1296-1302
    • Kovesdy, C.P.1    Ahmadzadeh, S.2    Anderson, J.E.3    Kalantar-Zadeh, K.4
  • 7
    • 33748430950 scopus 로고    scopus 로고
    • Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom
    • DOI 10.1038/sj.ki.5001726, PII 5001726
    • Hase H, Tsunoda T, Tanaka Y, Takahashi Y, Imamura Y, Ishikawa H, et al. Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney Int. 2006;70:1142-8. (Pubitemid 44344086)
    • (2006) Kidney International , vol.70 , Issue.6 , pp. 1142-1148
    • Hase, H.1    Tsunoda, T.2    Tanaka, Y.3    Takahashi, Y.4    Imamura, Y.5    Ishikawa, H.6    Inishi, Y.7    Joki, N.8
  • 8
    • 83055172414 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Suppl 3):S1-202.
    • (2003) Am J Kidney Dis , vol.42 , Issue.SUPPL. 3
  • 9
    • 77949496489 scopus 로고    scopus 로고
    • KDIGO Clinical practice guideline for the diagnosis, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
    • KDIGO Clinical practice guideline for the diagnosis, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(Suppl 113):S70-S89.
    • (2009) Kidney Int , vol.76 , Issue.SUPPL. 113
  • 10
    • 58149180225 scopus 로고    scopus 로고
    • Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients
    • Guideline Working Group, Japanese Society for Dialysis Therapy
    • Guideline Working Group, Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial. 2008;12:514-25.
    • (2008) Ther Apher Dial , vol.12 , pp. 514-525
  • 12
    • 70349279879 scopus 로고    scopus 로고
    • The impact of diabetes mellitus on vitamin D metabolism in predialysis patients
    • Tanaka H, Hamano T, Fujii N, Tomida I, Matsui S, Mikami Y, et al. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone. 2009;45:949-55.
    • (2009) Bone , vol.45 , pp. 949-955
    • Tanaka, H.1    Hamano, T.2    Fujii, N.3    Tomida, I.4    Matsui, S.5    Mikami, Y.6
  • 13
    • 0035922441 scopus 로고    scopus 로고
    • Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    • Renal study investigators
    • Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Renal study investigators, et al. Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:851-60.
    • (2001) N Engl J Med , vol.345 , pp. 851-860
    • Brenner, B.M.1    Cooper, M.E.2    De Zeeuw, D.3    Keane, W.F.4    Mitch, W.E.5    Parving, H.H.6
  • 15
    • 34249868434 scopus 로고    scopus 로고
    • Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats
    • DOI 10.1681/ASN.2006091028
    • Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, et al. Combination therapy with an angiotensinconverting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rat. J Am Soc Nephrol. 2007;18:1796-806. (Pubitemid 46870316)
    • (2007) Journal of the American Society of Nephrology , vol.18 , Issue.6 , pp. 1796-1806
    • Mizobuchi, M.1    Morrissey, J.2    Finch, J.L.3    Martin, D.R.4    Liapis, H.5    Akizawa, T.6    Slatopolsky, E.7
  • 17
  • 18
    • 0036073755 scopus 로고    scopus 로고
    • 3 is a negative endocrine regulator of the renin-angiotensin system
    • DOI 10.1172/JCI200215219
    • Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-38. (Pubitemid 34787360)
    • (2002) Journal of Clinical Investigation , vol.110 , Issue.2 , pp. 229-238
    • Li, Y.C.1    Kong, J.2    Wei, M.3    Chen, Z.-F.4    Liu, S.Q.5    Cao, L.-P.6
  • 19
    • 43049104680 scopus 로고    scopus 로고
    • Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial
    • DOI 10.1053/j.ajkd.2007.12.038, PII S0272638608001558
    • Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial. Am J Kidney Dis. 2008;51:724-31. (Pubitemid 351626254)
    • (2008) American Journal of Kidney Diseases , vol.51 , Issue.5 , pp. 724-731
    • Szeto, C.-C.1    Chow, K.-M.2    Kwan, B.C.-H.3    Chung, K.-Y.4    Leung, C.-B.5    Li, P.K.-T.6
  • 20
    • 69449097895 scopus 로고    scopus 로고
    • Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: Strong synergism with AT1 receptor antagonist
    • Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G, et al. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol. 2009;297:F791-801.
    • (2009) Am J Physiol Renal Physiol , vol.297
    • Zhang, Y.1    Deb, D.K.2    Kong, J.3    Ning, G.4    Wang, Y.5    Li, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.